Some people experience bouts of nausea in the first four weeks of using the drug, but this can become worse if the dose is escalated
The consultation process exists specifically to ensure the medication is safe for your individual situation
19 Another factor is that prediabetes and type 2 diabetes (T2D) are common in people with obesity, and T2D is associated with lower muscle mass and more rapid agerelated declines in muscle mass
However, it remains unknown whether hepatic GLP-1 resistance contributes to the poor treatment efficiency of GLP-1 in these patients
Research published in the New England Journal of Medicine found that participants on semaglutide lost weight consistently over 68 weeks, with most results continuing at week 104
FABP5 also channels PUFAs into cellular membranes, forming PUFA-containing phospholipids that are intrinsically vulnerable to lipid peroxidation and ferroptosis due to their bis-allylic structure with multiple double bonds [5]